UK markets closed

UniPharma Co., Ltd. (6621.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
13.10+0.75 (+6.07%)
At close: 02:59PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 450.86M
Enterprise value 276.96M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.37
Price/book (mrq)1.44
Enterprise value/revenue 2.68
Enterprise value/EBITDA -17.04

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-36.50%
S&P500 52-week change 322.36%
52-week high 321.35
52-week low 312.00
50-day moving average 313.27
200-day moving average 315.35

Share statistics

Avg vol (3-month) 365.92k
Avg vol (10-day) 351.86k
Shares outstanding 535.5M
Implied shares outstanding 636.07M
Float 8N/A
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -21.13%
Operating margin (ttm)-34.19%

Management effectiveness

Return on assets (ttm)-5.00%
Return on equity (ttm)-7.08%

Income statement

Revenue (ttm)103.22M
Revenue per share (ttm)2.89
Quarterly revenue growth (yoy)-28.60%
Gross profit (ttm)N/A
EBITDA -21.76M
Net income avi to common (ttm)-21.81M
Diluted EPS (ttm)-0.61
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)174.18M
Total cash per share (mrq)4.84
Total debt (mrq)272k
Total debt/equity (mrq)0.09%
Current ratio (mrq)6.09
Book value per share (mrq)8.68

Cash flow statement

Operating cash flow (ttm)12.03M
Levered free cash flow (ttm)15.66M